Depression Screening & Treatment in Primary Care: Part One

September 14, 2016 PCPCI

One in four individuals will struggle with a mental health or substance use disorder in their lifetime, yet only 40% of those seek treatment in a given year. Untreated mental health issues have a significant negative impact on quality of life and physical health, so addressing these issues in primary care could prevent health complications in the future. Join us for part one of this two-part webinar series that reviews the nuts and bolts of screening and treatment of depression in primary care. Universal depression screening is essential to meeting CCO metrics, but the processes and procedures that follow screening are essential to delivering comprehensive care.

Part 1 - Physician Overview of Treatment Gidelines - September 14, 2016

During this webinar, the presenters will:

  • Review existing clinical practice guidelines for medication and non-medication treatment of depression, including the research supporting non-medication management
  • Provide information on addressing depression for specific populations, including adolescents and older adults

Presented By:

Dr. Jonathan Betlinski
Chief Medical Officer & Medical Director for OHSU's Project ECHO
Cascadia Behavioral Healthcare

Jon’s love of community mental health stretches back to his days as a Resident Psychiatrist at the University of New Mexico, and here in Oregon includes work in Pendleton, Mitchell, Umatilla, Ontario, and at clinics around the Portland Metro Area from Forest Grove to Gresham. He’s also been blessed to serve in a variety of Medical Director and Associate Medical Director roles in community mental health, most recently as Cascadia’s Medical Director for both Emergency Services and the Plaza Clinic. Jon brings an academic perspective to Cascadia’s vision. He’s been on faculty at Oregon Health & Sciences University since 2006, where he remains a Clinical Associate Professor of Psychiatry. During his time at OHSU, Jon has served as the Associate Director of the Public Psychiatry Training Program, the Course Director for the Public Psychiatry seminar series, Medical Director for Project ECHO, and as an award-winning, core faculty member for the Psychiatry Residency, all while maintaining an active clinical role both on campus and in the community.

Dr. Ann Hamer
Clinical Pharmacy Manager at UnitedHealth Group & Psychiatric Pharmacy Consultant for OHSU’s Project ECHO
UnitedHealth Group

Dr. Ann Hamer is a highly trained, board certified psychiatric pharmacist with a diverse background as a pharmacy director, clinician and managed care specialist in both the public and private sectors. Dr. Hamer has experience working with Medicaid, Managed Medicaid, and Commercial health plans. Dr. Hamer’s interests center around the development and delivery of evidence-based interventions to improve prescribing practices while delivering cost-effective care.  Dr. Wheeler has over 15 years of experience working and teaching in the field of psychopharmacology.  She has presented at over 30 invited presentations and has contributed to over 30 peer reviewed publications. 

Click here to register for Part 2 - Workflow and Engaging the Clinical Team – October 5, 2016